Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Lamotrigine-XR in Elderly
NCT00789113Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lamotrigine in epilepsy and bipolar disorder (BD), sponsored by University of Minnesota. Primary endpoint: Area Under the Curve for Oral Bioavailability of Lamotrigine at 1 week. Started Nov 2008; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsybipolar disorder (BD)
Beyond the preview
Go deeper on NCT00789113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789113.